NDC 0280-1400

Alka-Seltzer Plus Cold Medicine Sparkling Original

Aspirin, Chlorpheniramine Maleate, And Phenylephrine Bitartrate

Alka-Seltzer Plus Cold Medicine Sparkling Original is a Oral Tablet, Effervescent in the Human Otc Drug category. It is labeled and distributed by Bayer Healthcare Llc.. The primary component is Aspirin; Chlorpheniramine Maleate; Phenylephrine Bitartrate.

Product ID0280-1400_724c678e-f48e-52b6-e053-2a91aa0a8ea1
NDC0280-1400
Product TypeHuman Otc Drug
Proprietary NameAlka-Seltzer Plus Cold Medicine Sparkling Original
Generic NameAspirin, Chlorpheniramine Maleate, And Phenylephrine Bitartrate
Dosage FormTablet, Effervescent
Route of AdministrationORAL
Marketing Start Date2008-04-10
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart343
Labeler NameBayer HealthCare LLC.
Substance NameASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE
Active Ingredient Strength325 mg/1; mg/1; mg/1
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 0280-1400-32

16 POUCH in 1 CARTON (0280-1400-32) > 2 TABLET, EFFERVESCENT in 1 POUCH
Marketing Start Date2008-04-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0280-1400-20 [00280140020]

Alka-Seltzer Plus Cold Medicine Sparkling Original TABLET, EFFERVESCENT
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2008-04-10
Marketing End Date2019-06-01

NDC 0280-1400-72 [00280140072]

Alka-Seltzer Plus Cold Medicine Sparkling Original TABLET, EFFERVESCENT
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2008-04-10
Marketing End Date2019-12-01

NDC 0280-1400-32 [00280140032]

Alka-Seltzer Plus Cold Medicine Sparkling Original TABLET, EFFERVESCENT
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2008-04-10

NDC 0280-1400-36 [00280140036]

Alka-Seltzer Plus Cold Medicine Sparkling Original TABLET, EFFERVESCENT
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2008-04-10
Marketing End Date2019-06-01

NDC 0280-1400-48 [00280140048]

Alka-Seltzer Plus Cold Medicine Sparkling Original TABLET, EFFERVESCENT
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2008-06-10
Marketing End Date2019-06-01

NDC 0280-1400-12 [00280140012]

Alka-Seltzer Plus Cold Medicine Sparkling Original TABLET, EFFERVESCENT
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2008-04-10
Marketing End Date2011-09-01

Drug Details

Active Ingredients

IngredientStrength
ASPIRIN325 mg/1

OpenFDA Data

SPL SET ID:78537dcf-b157-4b67-a8b2-5cb144815166
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1536840
  • Pharm Class PE
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
  • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
  • NUI Code
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722
  • NDC Crossover Matching brand name "Alka-Seltzer Plus Cold Medicine Sparkling Original" or generic name "Aspirin, Chlorpheniramine Maleate, And Phenylephrine Bitartrate"

    NDCBrand NameGeneric Name
    0280-1400Alka-Seltzer Plus Cold Medicine Sparkling OriginalASPIRIN, CHLORPHENIRAMINE MALEATE, and PHENYLEPHRINE BITARTRATE
    70264-015Alka-Seltzer Plus Cold Medicine Sparkling OriginalASPIRIN, CHLORPHENIRAMINE MALEATE, and PHENYLEPHRINE BITARTRATE
    66715-9735Alka-Seltzer PlusAspirin, Chlorpheniramine Maleate, and Phenylephrine Bitartrate
    0280-1440Alka-Seltzer Plus ColdAspirin, CHLORPHENIRAMINE MALEATE, and PHENYLEPHRINE BITARTRATE
    63868-228Quality Choice Effervescent Cold Relief PlusAspirin, Chlorpheniramine maleate, and Phenylephrine bitartrate
    67091-109WinCo Foods Effervescent Cold ReliefAspirin, Chlorpheniramine Maleate, and Phenylephrine Bitartrate

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.